British pharma firm claims small trial on a coronavirus treatment could signal 'major breakthrough'

British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized Covid-19 patients needing intensive care in a clinical trial.

from Health and Science https://ift.tt/2CTQGuU
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH